Fabulous to push the boundaries of #glioblastoma treatment with @johnboockvar @lenoxhill @NorthwellHealth and read about positive response of Daniel https://t.co/IK5nsuneIp using #EnGeneIC EDV tech.

We are currently enrolling #GBM patients for our EnGeneIC Dream Vector (EDVTM) nanocell-based technology, a new way of delivering chemotherapy drugs for the treatment of #braintumors. https://t.co/EUGTQusUoq @LenoxNeurosurg @NorthwellHealth 4 info please contact @ShereseFralin

Grateful to the entire team @LenoxNeurosurg and @lenoxhill who braved the #cyclonebomb today to help get our #glioma #meningioma and #encephalocele patients treated and also to our clinical trial team for treating two patients with the EnGeneIC EDV for #GBM. Incredible work.

Congrats to our @LenoxNeurosurg #braintumor research team for treating our first patient in @EnGeneIC EDV trial for #gbm @BrainCancerCure

We just opened this exciting trial with @EnGeneIC for the treatment of #Glioblastoma. Visit @LenoxNeurosurg for info

Very excited for our joint CEO @JenEnGene being announced as overall winner - innovation category of #100WOI. TY @FinancialReview & @Westpac